We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Quantitative Assays To Accelerate Therapeutic Antibody Development

Quantitative Assays To Accelerate Therapeutic Antibody Development
Credit: iStock

Therapeutic antibodies represent a powerful class of drugs used for the treatment of cancer, immune disease or viral infection.

In the development of new therapeutic antibodies, scientists must choose cell models and assays carefully to optimize functionality, ensuring that an appropriate immune response is activated through their interaction with Fc receptors expressed on the surface of immune cells.

This whitepaper explores the tools available to characterize antibody binding to Fc receptors, including quantitative assays to support optimization of therapeutic products.

Download this whitepaper to learn more about:

  • Immune signaling pathways and targets for therapeutic antibodies 
  • How to assay the effectiveness of antibodies against a range of Fc receptors
  • Kits to support the optimization of therapeutic antibodies and Fc receptor research


Access this Whitepaper for FREE Now!
Information you provide will be shared with the sponsors for this content. Technology Networks or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.